Research

While the NASDAQ increased modestly in Q3 2024, up 1.7% compared to Q2 2024 and 37.6% over the trailing 12-month period, healthcare technology segments have underperformed. Pharma IT and virtual care experienced  (28.4%) and (38.7%)…

Primary care and urgent care delivery models are converging as the healthcare industry continues to innovate around increasing access to quality, affordable care, fueling continued investment and M&A activity in the urgent care and primary…

Behavioral health focused revenue cycle management services and software companies are poised for outsized growth, according to a new industry report released by the Healthcare Outsourcing & Information Technology investment banking team from Brown Gibbons…

Revenue cycle management (RCM) services and software businesses are drawing the attention of an increasingly larger and wider array of investors than ever before, according to an industry report released by the Healthcare Outsourcing &…

The push for pharmaceutical innovation has prompted drug sponsors to streamline their supply chains and dedicate those resources toward faster product development. According to the Healthcare & Life Sciences Insider, an industry report released by…

Mergers and acquisitions activity in the fragmented Life Science Tools industry remains high, with consolidation expected to accelerate, according to the Healthcare & Life Sciences Insider, an industry report released by Brown Gibbons Lang &…

The BGL Healthcare & Life Sciences Insider is a periodic research publication addressing capital markets and mergers and acquisitions activity, financial and operating performance of certain publicly-traded companies, and trends within the healthcare and life…

The BGL Healthcare & Life Sciences Insider is a periodic research publication addressing capital markets and mergers and acquisitions activity, financial and operating performance of certain publicly-traded companies, and trends within the healthcare and life…

The Healthcare Insider is a periodic newsletter addressing capital markets and mergers & acquisitions activity, financial and operating performance of certain publicly-traded companies, and trends within the healthcare and life sciences industry. In this edition,…